Dry Powder Inhalers (DPI)

Abstract Lower respiratory tract infections (LRTIs) constitute the fourth leading cause of mortality worldwide, resulting in over two million deaths...

Abstract Background/Objectives: This study aims to investigate the underexplored impact of capsule type on the performances of capsule-based dry powder...

Abstract Dry Powder Inhaler (DPI) formulations generally consist of drug particles with a size between 1 and 5 µm, ideal for...

Abstract Magnesium stearate (MgSt) has been used as a force control agent (FCA) to enhance the aerosol performance of carrier-based...

Abstract The development of dry powder inhalers (DPIs) for pulmonary drug delivery is complex, requiring optimization of variable factors to...

Abstract There is growing demand for simplified collection of the fine particle dose (FPD, mass of particles less than 5 µm...

Abstract Background/Objectives: The integration of machine learning (ML) and artificial intelligence (AI) has revolutionized the pharmaceutical industry by improving drug...

Abstract Pulmonary drug delivery is a form of local targeting to the lungs in patients with respiratory disorders like cystic...

Abstract Amphotericin B (AmB) is used to treat Allergic Bronchopulmonary Aspergillosis (ABPA) caused by Aspergillus fumigatus. AmB is available in oral...

Introduction Pharmaceutical lactose by Amor Pharma is a cornerstone in both the pharmaceutical and food industries, valued for its versatility...